CEL-SCI Current Liabilities
The Current Liabilities of CEL-SCI (CVM) as of Oct 10, 2026 is 9.20 M USD. In the previous year, Current Liabilities was 7.78 M USD — a change of 18.20% (higher).
Get this data via API
Financial Data API
Current Liabilities
9.20 MUSD
YoY
18.20%
Last updated:
The CEL-SCI Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 9.20 MUSD | +18.20% | |
| 7.78 MUSD | -15.05% | |
| 9.16 MUSD | +18.84% | |
| 7.71 MUSD | +66.30% | |
| 4.64 MUSD | -13.12% | |
| 5.34 MUSD | +37.21% | |
| 3.89 MUSD | -61.38% | |
| 10.07 MUSD | -18.46% | |
| 12.35 MUSD | +157.09% | |
| 4.80 MUSD | -33.07% | |
| 7.18 MUSD | +84.21% | |
| 3.90 MUSD | -0.82% | |
| 3.93 MUSD | +74.68% | |
| 2.25 MUSD | -69.65% | |
| 7.41 MUSD | +124.82% | |
| 3.30 MUSD | -91.13% | |
| 37.17 MUSD | +860.01% | |
| 3.87 MUSD | +171.17% | |
| 1.43 MUSD | -32.26% | |
| 2.11 MUSD | +732.80% | |
| 253,133.00USD | -8.28% | |
| 275,981.00USD | -83.36% | |
| 1.66 MUSD | -24.60% | |
| 2.20 MUSD | +361.50% | |
| 476,509.00USD | -42.07% | |
| 822,601.00USD | +105.65% | |
| 400,000.00USD | 0.00% | |
| 400,000.00USD | -20.00% | |
| 500,000.00USD | -16.67% | |
| 600,000.00USD | -18.92% | |
| 740,000.00USD | +13.85% | |
| 650,000.00USD | -9.72% | |
| 720,000.00USD | +20.00% | |
| 600,000.00USD | 0.00% | |
| 600,000.00USD | +20.00% | |
| 500,000.00USD | -1.96% | |
| 510,000.00USD | -5.56% | |
| 540,000.00USD | +74.19% | |
| 310,000.00USD | -36.73% | |
| 490,000.00USD | +58.06% | |
| 310,000.00USD | — | |
| 0.00USD | -100.00% | |
| 120,000.00USD | — |
CEL-SCI Stock analysis
Frequently Asked Questions about CEL-SCI stock
Current Liabilities of CEL-SCI is 9.20 M USD in 2025.
Current Liabilities of CEL-SCI changed from 7.78 M USD to 9.20 M USD, representing a 18.20% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities CEL-SCI since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's CEL-SCI historically and in real time.
Balance Sheet — CEL-SCI
All Key Metrics — CEL-SCI
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth